Treating Patients With Opioid Use Disorder in Their Homes: An Emerging Treatment Model

This Viewpoint discusses the emergence of telehealth as a model for providing medication-assisted treatment (MAT) for opioid use disorder (OUD), and the advantages and disadvantages of the approach for underserved patient populations.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	JAMA : the journal of the American Medical Association 2020-07, Vol.324 (1), p.39-40
Hauptverfasser:	Uscher-Pines, Lori, Huskamp, Haiden A, Mehrotra, Ateev
Format:	Artikel
Sprache:	eng
Schlagworte:	Betacoronavirus Buprenorphine - therapeutic use Coronavirus Infections - epidemiology COVID-19 Drug addiction Drug and Narcotic Control - legislation & jurisprudence Health Expenditures Health Services Accessibility Home Care Services - trends Humans Narcotic Antagonists - therapeutic use Narcotics Opioid-Related Disorders - diagnosis Opioid-Related Disorders - therapy Opioids Pandemics Pharmaceutical Services, Online - legislation & jurisprudence Pneumonia, Viral - epidemiology Rural Health Services - statistics & numerical data SARS-CoV-2 Smartphone Substance use disorder Telemedicine Telemedicine - organization & administration Transportation of Patients - economics
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	This Viewpoint discusses the emergence of telehealth as a model for providing medication-assisted treatment (MAT) for opioid use disorder (OUD), and the advantages and disadvantages of the approach for underserved patient populations.
ISSN:	0098-7484 1538-3598
DOI:	10.1001/jama.2020.3940